Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ACHV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ACHV

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Achieve Life Sciences Inc

ACHV
Current price
2.32 USD -0.01 USD (-0.43%)
Last closed 2.33 USD
ISIN US0044685008
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 115 766 280 USD
Yield for 12 month -53.13 %
1Y
3Y
5Y
10Y
15Y
ACHV
21.11.2021 - 28.11.2021

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington. Address: 22722 29th Dr. SE, Bothell, WA, United States, 98021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

16.71 USD

P/E Ratio

Dividend Yield

Financials ACHV

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ACHV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-228 000 USD

Current Quarter

Last Quarter

EBITDA -45 747 000 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -59.02 %
PEG Ratio
Return On Equity TTM -154.55 %
Wall Street Target Price 16.71 USD
Revenue TTM
Book Value 0.30 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.35 USD
Diluted Eps TTM -1.35 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation ACHV

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.42
Price Book MRQ 11.46

Technical Indicators ACHV

For 52 Weeks

1.84 USD 5.31 USD
50 Day MA 2.99 USD
Shares Short Prior Month 2 971 805
200 Day MA 3.50 USD
Short Ratio 9.04
Shares Short 2 180 807
Short Percent 10.98 %